1 / 9

RVIPP Regional Meeting June 23-26, 2009 Indiana State Report

RVIPP Regional Meeting June 23-26, 2009 Indiana State Report. Dawne DiOrio Rekas, M.P.A. Assistant STD Program Manager IPP Coordinator. Topics to update. EPT progress Pregnancy-test only visit testing at Title X clinics Partner notification and treatment for IPP clinics

galya
Download Presentation

RVIPP Regional Meeting June 23-26, 2009 Indiana State Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. RVIPP Regional MeetingJune 23-26, 2009Indiana State Report Dawne DiOrio Rekas, M.P.A. Assistant STD Program Manager IPP Coordinator

  2. Topics to update • EPT progress • Pregnancy-test only visit testing at Title X clinics • Partner notification and treatment for IPP clinics • Data problems uncovered • 2008 Prevention Effectiveness • HEDIS measure/Whose data is it?

  3. EPT • Presented our request to Medical Licensing Board on March 26 • Regulation change requested prohibiting physician from prescribing or dispensing unless he has personally examined patient • MLB/OPLA; ISMA; Trial Lawyers Ass’n; State AG; ISDH attorney • Still no decision

  4. PTO Chlamydia screening • 4th quarter problems with implementation • 4th quarter 282 screened, 8% CT and 1% GC positivity • 1st Q 2009 – some improvement • 326 screened, 9% CT and 2% GC positivity • Only 7 clinics (of 29 eligible) sent specimens • Range of submissions per clinic: 5 to 147 • IFHC sent another directive to conduct testing

  5. Partner treatment • Form used by some (not all) clinics for partner info udpated and distributed to all IPP clinics and DIS statewide • Outcome of notification by DIS and treatment of partners reflected by STD*MIS data

  6. Data Problems • Three source files: ISDH Lab, Marion Co. Health Dept. Lab, and Center for Disease Detection (via Planned Parenthood) • 2008 not all files received or submitted to RVIPP • Data for provider type, selective screening site, etc. not accurate • Much appreciation to Charlie, Steve, and Shana for help

  7. Prevention effectiveness • CDC economic analysis tool – STICFigure Automatically calculates STD Program cost effectiveness as a result of program disease intervention (treatment of patients, partners, and case management) • Includes early syphilis, HIV, gonorrhea, and chlamydia • In 2008, Indiana’s STD Program saved $6.2M in medical costs (direct and indirect) • $2.60 saved for every $1 spent

  8. Indiana’s hedis measure Region V

  9. Whose data is it? • Managed care organizations requested access to CT screening data through ISDH Lab records and district STD sites • They proposed to send their patient list for us to match to verify if that patient had a CT test • Differing interpretations between local (STD district office) legal counsel and state counsel; HIPAA concerns; CDC involvement • Differing viewpoints on “fairness” of increasing HEDIS measure through IPP

More Related